Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: Potential clinical implications

Cancer Detection and Prevention

Volumn 26, Issue 3, 2002, Pages 222-228

  Mathew, Robin ^a   Khanna, Rinu ^a   Kumar, Rajesh ^a   Mathur, Meera ^a   Shukla, Nootan K ^a   Ralhan, Ranju ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Esophageal cancer; Invasion; ST 2

Indexed keywords

METALLOPROTEINASE; STROMELYSIN 2; TUMOR PROTEIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; MALE; MATRIX METALLOPROTEINASE 10; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0036931125     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00035-1     Document Type: Article

References (35)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1999;49:8-31.
2. Kohn EC, Liotta LA. Molecular insights into cancer invasion: Strategies for prevention and intervention. Cancer Res 1995;55:1856-62.
3. Shimada Y, Imamura G, Wantabe S, et al. Prognostic factors of esophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer 1999;80:1281-8.
4. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339:1453-7.
5. Stetler-Stevenson WG, Liotta LA, Kliener DE. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-41.
6. Tryggvason K, Hoyhta M, Pyke M. Type IV collagenases in invasive tumors. Breast Cancer Res Treat 1993;24:209-18.
7. Chambers AF, Matrisian LM. Changing view of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
8. Basset P, Okada A, Chenard MP, et al. Matrix metalloproteinases as stromal effectors of human carcinoma progression therapeutical implications. Matrix Biol 1997;15:535-41.
9. Johnsen M, Lund LR, Romer J, et al. Cancer invasion and tissues remodeling: Common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998;10:667-71.
10. Murphy G, Cockett MI, Ward RV, et al. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: A quantitative comparison of activities of 95 kd and 75 kd gelatinases, stromelysin-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991;277:277-9.
11. Breathnach R, Matrician LM, Gesnel MÇ, et al. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res 1987;15:1139-51.
12. Polette M, Claver C, Muller D, et al. Detection of mRNAs encoding collagenase-1 and stromelysin-2 in carcinoma of the head and neck by in situ hybridization. Invasion Metastasis 1991;11:76-83.
13. Windsor LJ, Grenett H, Birkedal-Hansen B, et al. Cell type specific regulation of SL-1 and SL-2 genes. Induction of SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbol esters. J Biol Chem 1993;268:17341-7.
14. Muller D, Breathnach R, Engelmann A, et al. Expression of collagenase-related metalloproteinase gene in human lung or head and neck tumors. Int J Cancer 1991;48:550-6.
15. Boddey B, Bodey Bela JR, Siegel S, et al. Immunohistochemical detection of MMP-3 and MMP-10 expression in hepatocellular carcinomas. Anticancer Res 2000;20:4585-90.
16. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992;70(12):2747-53.
17. Sato F, Shimada Y, Watanabe G, et al. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer 1999;80(9):1366-72.
18. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Patrol 1998;185(3):256-61.
19. Ohashi K, Nemoto T, Nakamura K, et al. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1 matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 2000;88(10):2201-9.
20. Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999;59(14):3313-6.
21. Yamashita K, Mori M, Kataoka A, et al. The clinical significance of MMP-1 expression in oesophageal carcinoma. Br J Cancer 2001;84(2):276-82.
22. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. Union Intemationale Contre le Cancer and the American Joint Committee on Cancer, 1997. Cancer 1997;80:1803-4.
23. Gaur D, Sonia A, Mathur M, Nath N, Chattopadhaya TK, Ralhan R. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: Correlation with dietary risk factors in India. Clin Cancer Res 1997;3:2129.
24. Uria JA, Otin CL. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 2000;60:4745-51.
25. Sternlicht MD, Lotcher A, Sympson CJ, et al. The stomal proteinase MMP-3/Stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
26. Yu Q, Stamenkovic I. Cell surface localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000;15:163-76.
27. Steller-Stevenson EG. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999;103:1237-41.
28. Remade AG, Neol A, Duggan C, et al. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer 1998;77(8):926-31.
29. Patterson BC, Sang QA. Angiostatin converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 1997;272:28823-5.
30. Lijnen HR, Ugwu F, Bini A, Collen D. Generation of angiostatin like fragment from plasminogen by stromelysin-1. Cell 1998;37:469-4702.
31. Dong Z, Kumar R, Yang X, Fidller IJ. Macrophage derived metalloelastase is responsible for generation of angiostatin in Lewis lung carcinoma. Cell 1997;88:801-10.
32. Saarailho-Kere UK, Pentland AP, Berkedal-Hansen H, et al. Distinct populations of basal keratincytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994;94:79-88.
33. Madlener M, Mauch C, Conca W, et al. Regulation of expression of stromelysin-2 by growth factors in keratinocytes: Implications for normal and impaired wound healing. Biochem J 1996;320:659-64.
34. van den Oord JJ, Paemen L, Opdenakker G, de Wolf Peeters. Expression of gelatinase B an the extracellular matrix metallo-proteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 1997;151:665-670.
35. Yamashita K, Mori M, Shiraishi T, et al. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000;6(3):1169-74.